Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
She is a participant in a speakers bureau for Abbott Diabetes Care and Xeris
As T2D is often associated with having a high body mass index, one would be forgiven for assuming that the needs of people who use GLP-1s for weight loss and those using it to treat diabetes would be very similar, but recent market research suggests a number of significant differences:5 The majority of people using GLP-1s for weight loss are in their 30s to 50s (often as part of a wider strategy to be proactive about their health), whereas those using GLP-1s for diabetes control are more likely to be over 60
Integrated Support: Care may align with hormone optimization and metabolic services for people of all genders
Understanding these predispositions can support a more informed baseline assessment and help guide personalized hydration and monitoring strategies
